Document is current
Any future updates will be listed below
-
Authors
Oks, David
Reza, Symon
Vázquez, Mariano
Houzeaux, Guillaume
Kovarovic, Brandon
Samaniego, Cristóbal
Bluestein, Danny https://orcid.org/0000-0002-4014-2308
-
Funding
Funding for this research was provided by:
HORIZON EUROPE Marie Sklodowska-Curie Actions (LCF/BQ/DI18/11660044)
National Institute of Biomedical Imaging and Bioengineering (U01EB026414)
CompBioMed2 (823712)
- License Information
-
More Information
Article History
Received: 23 August 2023
Accepted: 3 December 2023
First Online: 14 December 2023
Declarations
:
: Author D.B. has an equity interest in Polynova Cardiovascular Inc. Author B.K. is a consultant of Polynova Cardiovascular Inc. Author M.V. is the CTO/CSO of ELEM Biotech S.L. Author D.O. is a Business Development Engineer at ELEM Biotech S.L. Author G.H. and C.S. have equity interests in ELEM Biotech S.L. The other authors declare that they have no competing interests.
: The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of Stony Brook University (2013-2357-R5, 2 October 2022).
